期刊文献+

大鼠补体C5a蛋白真核、原核表达载体的构建以及体外表达的鉴定、纯化和生物学活性分析 被引量:1

Construction,identification,purification and biological activity of eukaryotic and prokaryotic expression vector of rat complement C5a
下载PDF
导出
摘要 目的:构建带His标签的大鼠补体C5a蛋白真核表达载体pIRES2-EGFP-C5a和原核表达载体pET-21a-C5a,分别观察其体外表达情况,将C5a蛋白纯化后分析其生物学活性。方法:以RT-PCR方法从大鼠肝细胞中扩增出大鼠补体C5a基因全长cDNA序列,在序列的N端添加6个组氨酸His标签后,插入含增强绿色荧光蛋白的真核表达质粒pIRES2-EGFP,用脂质体法转染HEK293细胞,免疫印迹法检测C5a蛋白的表达水平;以真核表达质粒pIRES2-EGFP-C5a为基础,将大鼠补体C5a基因亚克隆至原核表达载体pET-21a,体外检测C5a蛋白的表达情况,之后再行Ni2+螯合亲和层析柱纯化C5a蛋白。以C5a刺激中性粒细胞,流式细胞仪检测细胞内活性氧的生成;C5a刺激大鼠肾小球系膜细胞(GMC)不同时间,RT-PCR测定其产生IL-6和TNF-α的水平。结果 :RT-PCR扩增出了大鼠补体C5a基因;并成功构建了pIRES2-EGFP-C5a重组质粒,体外成功转染入HEK293细胞,并在荧光显微镜下可见强绿色荧光蛋白的表达,但免疫印迹法未能检出C5a蛋白的表达;另成功构建了pET-21a-C5a原核表达载体,并在体外用免疫印迹法检测到了C5a蛋白表达。另用亲和层析纯化得到了带His标签的C5a蛋白,证实C5a能促进中性粒细胞呼吸氧爆发。结论:成功构建了大鼠补体C5a真核和原核表达载体。构建的原核表达载体可测到C5a蛋白的表达,且C5a蛋白具有相应的生物学活性。 Objective:To construct eukaryotic expression vector pIRES2-EGFP-CSa,prokaryotic expression vector pET-21a-CSa of rat complement C5a containing histidine tag, and observe its expression and biological activity in vitro. Methods:Total RNA was isolated from rat liver cells, C5a gene was amplified by reverse transcriptional PCR and inserted into pIRES2-EGFP vector. After lipofectamine-mediated transfeetion of HEK293 cells with pIRES2-EGFP plasmid,the expression of rat C5a protein was determined by fluorescence microscope and Western blot. The prokaryotic expression vector of pET-21a-C5a was constructed,and the expression of C5a protein was determined by Western blot. Rat CSa was purified by Ni2. chelating affinity chromatography column. The reactive oxidative species (ROS) generated from neutrophils which were stimulated by C5a was detected by flow analyzer. The mRNA of IL-6 and TNF-α was detected after rat GMCs were stimulated by C5a for different time. Results:The rat complement C5a gene was amplified by reverse transcriptional PCR successfully. The pIRES2-EGFP-C5a plasmid was successfully constructed and tranfeeted into HEK293 cells. The expression of green fluorescent protein was seen under by fluorescence microscopy,but no C5a was detected. Meantime,the pET-21a-C5a plasmid was also constructed,and the expression of C5a could be detected using Western blot. And the histidine tagged C5a protein was purified by Ni2+ chelating affinity chromatography column. C5a can stimulate the nertrophils to generate ROS. Conclusion:The pIRES2-EGFP-C5a plasmid and pET-21a-C5aplasmid were successfully constructed,and the expression of C5a in prokaryotic expression vector pET-21a-CSa could be detected and the product was biological active.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2013年第10期1344-1350,共7页 Journal of Nanjing Medical University(Natural Sciences)
基金 国家自然科学基金(81072402 8127333)
关键词 补体C5A 质粒构建 真核表达 原核表达 生物学活性 C5a plasmid construction eukaryotic expression prokaryotic experssion biological activity
  • 相关文献

参考文献15

  • 1Wetsel RA, Lemons RS, Le Beau MM. Moleclar analysis of human complement component C5: localization of the structure gene to chromosome 9[J]. Biochemistry, 1988, 27(5): 1474-1482.
  • 2Monk PN, Scola AM, Madala P. Function, structure and therapeutic potential of complement C5a receptors[J]. BrJ Pharmacol, 2007 , 152( 4) : 429-448.
  • 3KohlJ. Self,non-self,and danger- a complementary view[J]. Adv Exp Med Binl,2006,586(1):71-94.
  • 4Boshra H, Peters R, LiJ. Production of recombinant C5a from rainbow trout (Oncorhynchus mykiss l , role in lercocyte chemotaxis and respiratort burst[J]. Fish Shellfish Immunol, 2004 , 17 ( 3 ) : 293- 303.
  • 5Guo RF , Ward PA. Role of C5a in inflammatory responses[J]. Annu Rev Immunol,2005,23:821-852.
  • 6Flierl MA, Perl M, Rittirsch D. The role of C5a in the in?nate immune response after experimental blunt chest trauma[J]. Shock ,2008 ,29( 1): 25-31.
  • 7Gressner OA,Koch A,Sanson E. High C5a levels are as?sociated with increased mortality in sepsis patients-no enhancing effect by actin-free Gc-globulin[J]. Clin Biochem, 2008 ,41 (12): 974-980.
  • 8Pan H,Shen Z,Mukhopadhyay P. Anaphylatoxin C5a con?tributes to the pathogenesis of cisplatin-induced nephrotox?icity[J]. AmJ Physiol Renal Physiol,2009,296(3) :F496- f504.
  • 9Szeplaki G, Varga L, Fust G. Role of complement in the pathomechanism of atherosclerotic vascular diseases[J]. Mol Immunol,2009,46(l4) :2784-2793.
  • 10Marigo I,Dolcetti L,Serafini P. Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells[J]. Immunol Rev, 2008 ,222: 162-179.

二级参考文献17

  • 1Michael H, Merson M D. The HIV-AIDS pandemic at 25-the global response [ J ]. New Engl. J. Med. , 2006,354:2414 -2417.
  • 2Girard M P, Osmanov S K, Kieny M P. A review of vaccine research and development the human imm-unodeficiency virus ( HIV )[J]. Vaccine, 2006,24:4062 - 4081.
  • 3Jose E. The global HIV vaccine enterprise [ J ]. Int. Microbiol. , 2005,8:93 - t01.
  • 4Heeney J L, Hahn B H. Vaccines and immunology: Elucida- ting immunity to HIV-1 and current prospects for AIDS vaccine development[ J]. AIDS, 2000,14 (S) : 125 - 127.
  • 5Klein E, Ho R J. Challenges in the development of an effective HIV vaccine: Current approaches and future directions [ J ]. Clin. Ther. , 2000,22:295-314.
  • 6Cheng M C. Biological and molecular features of HIV related to tissue tropism [ J 1. AIDS, 1990,4 (S) :49 - 56.
  • 7Chen B, Vogan E M, Gong H, et al.. Structure of an unliganded simian immunodeficiency virus gpl20 core [ J ]. Nature ,2005,433:834 - 840.
  • 8Kim Y B, Han D P, Cao c,et al.. Immunogenicity and ability of variable loop-deleted Human immunodeficiency virus type 1 envelope glyeoprotein to elicit neutralizing antibodies [ J ]. Virology, 2003, ( 305 ) : 124 - 137.
  • 9Kahler S. Immunologic response to EIAV offers hope for AIDS treatment[J]. J. Am. Vet. Med. Assoc.,1992,201(ll): 1672 - 1673.
  • 10Cook R F, Berger S L, Rushlow K E, et al.. Enhanced sensitivity to neutralizing antibodies in a variant of equine infectious anemia virus is linked to amino acid substitutions in t he surface unit envelope glycoprotein [J]. J.Virol. , 1995,69 : 1493 - 1499.

共引文献1

同被引文献11

  • 1夏炎火,姚华国,张媛莉.C5a-C5aR在脓毒症中的作用[J].国际内科学杂志,2007,34(3):184-186. 被引量:1
  • 2Manthey H D, Woodruff T M, Taylor S M,et al.Complement component 5a (C5a) [J], Int J BiochemCell Biol,2009,41(11) :2114-2117.
  • 3Arumugam T V,Magnus T? Woodruff T M, et al.Complement mediators in is chemia- reperfusion in-jury[J]. Clin Chim Acta,2006,374(1) :33-45.
  • 4Woodruff T M,Pollitt S,Proctor L M,et al. Increasedpotency of a novel complement factor 5a receptor an-tagonist in a rat model of inflammatory bowel disease[J], J Pharmacol Exp Ther,2005,314(2) :811-817.
  • 5Woodruff T M,Strachan A J^Dryburgh N,et al. Anti-arthritic activity of an orally active C5a receptor an-tagonist against antigen-induced monarticular arthri-tis in the rat[J]. Arthritis Rheum-US,2002,46 (9):2476-2485.
  • 6Strachan A J, Woodruff T M, Haaima G,et al. A newsmall molecule C5a receptor antagonist inhibits thereverse-passive Arthus reaction and endotoxic shockin rats[J]. J Immunol,2000,164( 12) :6560-6565.
  • 7Woodruff T M,Costantini K J , Taylor S M,et al. Roleof complement in motor neuron disease:animal mod-els and therapeutic potential of complement inhibi-tors[J]. Adv Exp Med Biol,2008,632(13) : 143-158.
  • 8Gerard Huglig T E. Anaphylatoxin from the fifthcomponent of porcine complement [J]. Biol Chem,1979,254(14);6346-6351.
  • 9Hezmeea M N M, Shiels I A, Rolfe B E,et al. Com-plement C5a: impact on the field of veterinary medi-cine[J]. Vet J,2012,192:264-271.
  • 10Gerard C,Hugli 丁 E. Amino Acid Sequence of theAnaphylatoxin from the fifth component of porcinecomplement J ]. Biol Chem, 1980, 255 ( 10 ): 4710-4715.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部